Holding(s) in Company

DUBLIN--()--

STANDARD FORM TR-1

VOTING RIGHTS ATTACHED TO SHARES– ARTICLE 12(1) OF DIRECTIVE 2004/109/EC

FINANCIAL INSTRUMENTS – ARTICLE 11(3) OF THE COMMISSION DIRECTIVE 2007/14/EC1

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached 2:

Mainstay Medical International plc

2. Reason for the notification (please tick the appropriate box or boxes):

[X] an acquisition or disposal of voting rights

an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

an event changing the breakdown of voting rights

3. Full name of person(s) subject to the notification obligation3:

FCPI BIO SANTE

4. Full name of shareholder(s) (if different from 3.) :

N/A

5. Date of the transaction and date on which the threshold is crossed or reached4:

2 May 2014

6. Date on which issuer notified;

5 May 2014

7. Threshold(s) that is/are crossed or reached:

N/A

8. Notified details:

A) Voting rights attached to shares
Class/type of shares (if possible using the ISIN CODE)  

Situation previous to the Triggering transaction 5

 

Resulting situation after the triggering transaction6

 

 

Number of Shares7

 

Number of Voting rights8

Number of shares9

 

Number of voting rights10

  % of voting rights
Direct

Direct11

  Indirect Direct   Indirect
IE00BJYS1G50

BIO SANTE

125 001 125 001 143068 143068 0 3.36 %

0 %

IE00BJYS1G50

SG INNOVATION 2011

34 436 34 436 39 787 39 787 0 0.93 % 0 %
IE00BJYS1G50

ISF 4

11 478 11 478 11478 11478 0 0.27 % 0 %
SUBTOTAL A

SEVENTURE PARTNERS

(based on aggregate voting rights)

170 915 170 915 194 333 194 333 4.57 %
B) Financial Instruments

Resulting situation after the triggering transaction12

Type of financial instrument  

Expiration Date13

 

Exercise/Conversion Period/ Date14

  Number of voting rights that may be acquired if the instrument is exercised/converted   % of voting rights
 

 

     
         
SUBTOTAL B (in relation to all expiration dates)    
Total (A+B)   number of voting rights   % of voting rights
  194 333 4.57 %

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable15:

N/A

10. In case of proxy voting:

N/A

11. Additional information:

FCPI BIO SANTE + FCPI SG INNOVATION 2011 + FCPI ISF 4 are jointly manage by Seventure Parners & Amundi Private Equity

ANNEX TO THE STANDARD FORM TR-1 16

a) Identity of the person or legal entity subject to the notification obligation:

Full name (including legal form for legal entities)   SEVENTURE PARTNERS
Contact address (registered office for legal entities) 5/7 RUE DE MONTTESSUY

75340 PARIS CEDEX 07

Phone number +33 1 58 19 22 70
Other useful information (at least legal representative for legal persons)

b) Identity of the notifier, if applicable17:

Full name   Mme Isabelle de CREMOUX
Contact address 5/7 RUE DE MONTTESSUY

– 75340 PARIS CEDEX 07

Phone number +33 1 58 19 22 70
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) M.Emmanuel FIESSINGER

c) Additional information

N/A

Notes to Form TR-1

1 This form is to be sent to the issuer or underlying issuer and to be filed with the competent authority.

2 Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.

3 This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in Article 10 (b) to (h) of Directive 2004/109/EC; (c) all the parties to the agreement referred to in Article 10 (a) of that Directive, or (d) the holder of financial instruments entitled to acquire shares already issued to which voting rights are attached, as appropriate.

In relation to the transactions referred to in points (b) to (h) of Article 10 of that Directive, the following list is provided as indication of the persons who should be mentioned:

- in the circumstances foreseen in letter (b) of Article 10 of that Directive, the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

- in the circumstances foreseen in letter (c) of Article 10 of that Directive, the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

- in the circumstances foreseen in letter (d) of Article 10 of that Directive, the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

- in the circumstances foreseen in letter (e) of Article 10 of that Directive, the controlling natural person or legal entity and, provided it has a notification duty at an individual level under Article 9, under letters (a) to (d) of Article 10 of that Directive or under a combination of any of those situations, the controlled undertaking;

- in the circumstances foreseen in letter (f) of Article 10 of that Directive, the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

- in the circumstances foreseen in letter (g) of Article 10 of that Directive, the natural person or legal entity that controls the voting rights;

- in the circumstances foreseen in letter (h) of Article 10 of that Directive, the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion.

4 The date of the transaction should normally be, in the case of an on exchange transaction, the date on which the matching of orders occurs; in the case of an off exchange transaction, date of the entering into an agreement. The date on which threshold is crossed should normally be the date on which the acquisition, disposal or possibility to exercise voting rights takes effect. For passive crossings, the date when the corporate event took effect.

5 Please refer to the situation disclosed in the previous notification. In case the situation previous to the triggering transaction was below 3%, please state "below 3%".

6 If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is below 3%.

For the case provided for in Article 10(a) of Directive 2004/109/EC, there should be no disclosure of individual holdings per party to the agreement unless a party individually crosses or reaches an Article 9 threshold. This applies upon entering into, introducing changes to or terminating an agreement.

7 To be used in Member States where applicable.

8 Direct and indirect.

9 To be used in Member States where applicable.

10 In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns – if there is no combined holdings, please leave the relevant box blank.

11 Voting rights attached to shares held by the notifying party (Article 9 of Directive 2004/109/EC).

12 If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is below 3%.

13 Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

14 If the financial instrument has such a period – please specify this period – for example once every 3 months starting from [date].

15 The notification should include the name(s) of the controlled undertakings through which the voting rights are held. The notification should also include the amount of voting rights and the percentage held by each controlled undertaking, insofar as individually the controlled undertaking holds 3% or more, and insofar as the notification by the parent undertaking is intended to cover the notification obligations of the controlled undertaking.

16 This annex is only to be filed with the competent authority.

17 Whenever another person makes the notification on behalf of the shareholder or the natural person/legal entity referred to in Articles 10 and 13 of Directive 2004/109/EC

Short Name: Mainstay Medical Intl. PLC
Category Code: HOL
Sequence Number: 417271
Time of Receipt (offset from UTC): 20140512T121356+0100

Contacts

Mainstay Medical Intl. PLC

Sharing

Contacts

Mainstay Medical Intl. PLC